The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect
In 2025, over 1 million patients accessed Lilly treatments through LillyDirect
This is the first controlled pharmacologic study to demonstrate that treatment of obesity improved PsA disease measures
Patients can now get the starting 2.5 mg dose for $299 per month
Walmart, with nearly 4,600 pharmacies nationwide, will serve as the first in-store pickup pharmacy for LillyDirect's self-pay single-dose vials
Express Scripts to add Zepbound to National Preferred Formulary
Lilly has long voiced concerns over mass-compounded knockoffs of its tirzepatide medicines, Mounjaro and Zepbound
Starting January 1, 2027, Lilly’s Zepbound (tirzepatide), Mounjaro (tirzepatide), and orforglipron, if approved, will be available through participating Medicare Part D plans
CagriSema produced a 23% weight loss at 84 weeks, versus 25.5% for tirzepatide
The trial targeted a patient population with high BMI and extensive skin involvement, averaging over 39 kg/m²
Subscribe To Our Newsletter & Stay Updated
